ZBH
65
-3
VRTX
49
3
RCL
64
3
DUK
60
5
GLW
50
-2
WBA
43
-5
NI
65
9
YUM
33
-2
MLM
32
5
MUR
38
3
MCK
56
3
EIX
47
-11
PNW
55
2
SE
65
5
NEE
41
2
LB
64
4
ALLE
19
3
LYB
34
-2
TGT
54
-3
ABBV
51
-4
ZBH
65
-3
VRTX
49
3
RCL
64
3
DUK
60
5
GLW
50
-2
WBA
43
-5
NI
65
9
YUM
33
-2
MLM
32
5
MUR
38
3
MCK
56
3
EIX
47
-11
PNW
55
2
SE
65
5
NEE
41
2
LB
64
4
ALLE
19
3
LYB
34
-2
TGT
54
-3
ABBV
51
-4
Financhill
Back

Cytokinetics Vs. Novo Nordisk AS Industry Stock Comparison

Sell
21

CYTK
Cytokinetics

Last Price:
$46.55
Seasonality Move:
-1.45%
Sell
25

NVO
Novo Nordisk AS

Last Price:
$86.04
Seasonality Move:
6.68%
Sell
21
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $47.37. The Score for CYTK is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.64. The Score for NVO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $47.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing selling pressure, which indicates risk of future bearish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.64
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.72 Sell
Relative Strength Index (14 RSI): 41.28 Sell
Chaikin Money Flow: -616553 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.53 - 50.37) Sell
Bollinger Bands (100): (49.73 - 55.87) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.06 Sell
Relative Strength Index (14 RSI): 31.71 Sell
Chaikin Money Flow: 6521757 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.72 - 109.1) Sell
Bollinger Bands (100): (99.51 - 129.55) Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.11 Sell
20-day SMA: 48.5 Sell
50-day SMA: 50.75 Sell
200-day SMA: 56.16 Sell
8-day EMA: 48.27 Sell
20-day EMA: 48.75 Sell
50-day EMA: 50.34 Sell
200-day EMA: 53.74 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 86.04 Sell
20-day SMA: 94.95 Sell
50-day SMA: 102.54 Sell
200-day SMA: 123.74 Sell
8-day EMA: 86.81 Sell
20-day EMA: 92.64 Sell
50-day EMA: 101.62 Sell
200-day EMA: 114.8 Sell

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.29 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.54 per share.

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):